kabutan

CREATE MEDIC, First Half Ordinary Profit Increases by 52%

Tue Aug 5, 2025 11:30 am JST Earnings

5187 CREATE MEDIC CO.,LTD. 【J-GAAP】

Earnings Report

CREATE MEDIC CO.,LTD. <5187> [TSE Std] announced its financial results at noon (11:30) on August 5th. The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded 0.52 billion yen, an increase 52.2% compared to the same period last year, exceeded the previous forecast of 0.35 billion yen.

Progress toward the full-year plan of 1.04 billion yen was 50.3%, almost the same as the five-year average of 47.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to December period (second half) is expected to grow 27.9% from the same period last year, reaching 0.51 billion yen.

In the most recent three-month period, from April to June (2Q), the consolidated ordinary profit grew 29.7% from the same period last year, reaching 0.31 billion yen. The operating profit margin significantly improved from 5.8% in the same period last year to 9.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 6,025 335 371 316 34.8 42.5 Aug 4, 2023 J-GAAP
Jan - Jun, 2024 6,300 291 345 550 61.4 46.0 Aug 5, 2024 J-GAAP
Jan - Jun, 2025 6,564 548 525 412 48.4 50.3 Aug 5, 2025 J-GAAP
YoY +4.2% +88.3% +52.2% -25.1% -21.2%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance 6,397 309 352 192 22.6 17 Feb 13, 2025 J-GAAP
Jan - Jun, 2025 Results 6,564 548 525 412 48.4 17 Aug 5, 2025 J-GAAP
Revision Rate +2.6% +77.3% +49.1% +114.6% +113.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 6,730 401 405 290 32.9 20 Feb 13, 2025 J-GAAP
Jul - Dec, 2025 Guidance 7,019 454 518 384 45.8 20 Aug 5, 2025 J-GAAP
YoY +4.3% +13.2% +27.9% +32.4% +39.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 12,585 803 872 154 16.9 37 Feb 14, 2024 J-GAAP
Dec, 2024 13,030 692 750 840 95.4 39 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance 13,583 1,002 1,043 796 94.9 37 Feb 13, 2025 J-GAAP
YoY +4.2% +44.8% +39.1% -5.2% -0.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 3,324 193 239 491 54.8 5.8 Aug 5, 2024 J-GAAP
Jul - Sep, 2024 3,212 230 200 194 21.9 7.2 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 3,518 171 205 96 10.9 4.9 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 3,220 221 215 209 24.4 6.9 May 7, 2025 J-GAAP
Apr - Jun, 2025 3,344 327 310 203 23.8 9.8 Aug 5, 2025 J-GAAP
YoY +0.6% +69.4% +29.7% -58.7% -56.5%

Related Articles